Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep;81(1):62–68. doi: 10.1038/sj.bjc.6690651

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

J-P Collet 1,2, C Sharpe 1,2, E Belzile 1, J-F Boivin 1,2, J Hanley 2, L Abenhaim 1,2
PMCID: PMC2374346  PMID: 10487613

Abstract

Epidemiological studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal cancer incidence. We measured the rate ratio for colorectal adenocarcinoma according to dosage and the timing of exposure by means of a case–control study, nested in a non-concurrent cohort linkage study, using the population of beneficiaries of the Saskatchewan Prescription Drug Plan from 1981 to 1995 with no history of cancer since 1970 as the source population. Four controls per case, matched on age and gender and alive when the case was diagnosed, were randomly selected. Dispensing rates, calculated over successive time periods, characterized NSAID exposure. We accrued 3844 cases of colon cancer and 1971 cases of rectal cancer. For colon cancer a significant trend towards a decreasing rate ratio was associated with increasing exposure during the 6 months preceding diagnosis (P-trend = 0.002). For both cancers, significant trends were associated with exposure 11–15 years before diagnosis (colon: P-trend = 0.01; rectum: P-trend = 0.0001). At the highest exposure levels the rate ratio for colon cancer was 0.57 (95% confidence interval (CI) 0.36–0.89); for rectal cancer it was 0.26 (95% CI 0.11–0.61). No protection was associated with exposure during other periods. The timing of NSAID use must be considered in planning intervention trials to prevent colorectal cancer. There may be a 10-year delay before any preventive effect will appear. © 1999 Cancer Research Campaign

Keywords: colorectal cancer, non-steroidal anti-inflammatory drugs, epidemiology, case–control studies

Full Text

The Full Text of this article is available as a PDF (97.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkel H., Holcombe R. F., Middlebrooks M., Kannan K. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev. 1996;18(2):205–217. doi: 10.1093/oxfordjournals.epirev.a017926. [DOI] [PubMed] [Google Scholar]
  2. Brenner H., Gefeller O. Use of the positive predictive value to correct for disease misclassification in epidemiologic studies. Am J Epidemiol. 1993 Dec 1;138(11):1007–1015. doi: 10.1093/oxfordjournals.aje.a116805. [DOI] [PubMed] [Google Scholar]
  3. Carson J. L., Strom B. L., Morse M. L., West S. L., Soper K. A., Stolley P. D., Jones J. K. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1987 Jun;147(6):1054–1059. [PubMed] [Google Scholar]
  4. Gann P. H., Manson J. E., Glynn R. J., Buring J. E., Hennekens C. H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993 Aug 4;85(15):1220–1224. doi: 10.1093/jnci/85.15.1220. [DOI] [PubMed] [Google Scholar]
  5. Giovannucci E., Colditz G. A., Stampfer M. J., Hunter D., Rosner B. A., Willett W. C., Speizer F. E. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 1994 Feb 2;86(3):192–199. doi: 10.1093/jnci/86.3.192. [DOI] [PubMed] [Google Scholar]
  6. Giovannucci E., Egan K. M., Hunter D. J., Stampfer M. J., Colditz G. A., Willett W. C., Speizer F. E. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep 7;333(10):609–614. doi: 10.1056/NEJM199509073331001. [DOI] [PubMed] [Google Scholar]
  7. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Kearney J., Willett W. C. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst. 1994 Feb 2;86(3):183–191. doi: 10.1093/jnci/86.3.183. [DOI] [PubMed] [Google Scholar]
  8. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994 Aug 15;121(4):241–246. doi: 10.7326/0003-4819-121-4-199408150-00001. [DOI] [PubMed] [Google Scholar]
  9. Gridley G., McLaughlin J. K., Ekbom A., Klareskog L., Adami H. O., Hacker D. G., Hoover R., Fraumeni J. F., Jr Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993 Feb 17;85(4):307–311. doi: 10.1093/jnci/85.4.307. [DOI] [PubMed] [Google Scholar]
  10. Lundholm K., Gelin J., Hyltander A., Lönnroth C., Sandström R., Svaninger G., Körner U., Gülich M., Kärrefors I., Norli B. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994 Nov 1;54(21):5602–5606. [PubMed] [Google Scholar]
  11. Marshall J. R., Priore R., Graham S., Brasure J. On the distortion of risk estimates in multiple exposure level case-control studies. Am J Epidemiol. 1981 Apr;113(4):464–473. doi: 10.1093/oxfordjournals.aje.a113114. [DOI] [PubMed] [Google Scholar]
  12. Newcomb P. A., Storer B. E. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst. 1995 Jul 19;87(14):1067–1071. doi: 10.1093/jnci/87.14.1067. [DOI] [PubMed] [Google Scholar]
  13. Paganini-Hill A., Chao A., Ross R. K., Henderson B. E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989 Nov 18;299(6710):1247–1250. doi: 10.1136/bmj.299.6710.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peleg I. I., Lubin M. F., Cotsonis G. A., Clark W. S., Wilcox C. M. Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci. 1996 Jul;41(7):1319–1326. doi: 10.1007/BF02088554. [DOI] [PubMed] [Google Scholar]
  15. Pollard M., Luckert P. H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science. 1981 Oct 30;214(4520):558–559. doi: 10.1126/science.7291992. [DOI] [PubMed] [Google Scholar]
  16. Potter J. D., Slattery M. L., Bostick R. M., Gapstur S. M. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15(2):499–545. doi: 10.1093/oxfordjournals.epirev.a036132. [DOI] [PubMed] [Google Scholar]
  17. Risch H. A., Howe G. R. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol. 1994 Apr 1;139(7):670–683. doi: 10.1093/oxfordjournals.aje.a117057. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg L., Palmer J. R., Zauber A. G., Warshauer M. E., Stolley P. D., Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991 Mar 6;83(5):355–358. doi: 10.1093/jnci/83.5.355. [DOI] [PubMed] [Google Scholar]
  19. Rothman K. J. Induction and latent periods. Am J Epidemiol. 1981 Aug;114(2):253–259. doi: 10.1093/oxfordjournals.aje.a113189. [DOI] [PubMed] [Google Scholar]
  20. Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994 Mar;5(2):138–146. doi: 10.1097/00001648-199403000-00003. [DOI] [PubMed] [Google Scholar]
  21. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES